Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
65,437 trials
Arthritis, Rheumatoid
Primary: Number of Subjects Experiencing Any Adverse Event — 76 participants
Healthy
Primary: Bioequivalence Based on Cmax — 3008.88; 3086.02 ng/mL
Healthy
Primary: Cmax (Maximum Observed Concentration) — 16.595; 16.744 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 2440.545; 2414.955 ng/mL
Pulmonary Arterial Hypertension, Children
Primary: Percent Change From Baseline in Peak Volume of Oxygen (VO2) Consumed : Intent To Treat Population — 6.44; 13.40; 10.58; 10.24 percent change — p=0.056
Healthy
Primary: Cmax - Maximum Observed Concentration - for Total Ursodiol — 6763.805; 7461.161 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 2170.964; 2214.636 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration - for Total Ursodiol — 4946.800; 5026.891 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 465.66; 449.85 ng/mL
Healthy
Primary: Cmax (Maximum Observed Concentration) — 12.024; 11.9 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 1515.00; 1464.10 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 376.46; 398.06 ng/mL
Healthy
Primary: Cmax (Maximum Observed Concentration) — 2995.84; 3063.65 ng/mL
Healthy
Primary: Cmax (Maximum Observed Concentration) — 2638.063; 2557.122 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 11.0939; 11.1715 µg/mL